Delivery Order SPE2DB20D3101-SPE2DB24FQXP2
- Not listed
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,775,064 units of the pharmaceutical product TELMISARTAN-AMLODIPINE 40-5 MG 30S. The contract has a completion date of February 27, 2024 and a potential value of $2,958.74. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which falls under a larger indefinite...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,011.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TELMISARTAN-AMLODIPINE 80-10 30S medication. This delivery order contract has a completion date of January 31, 2024 and was awarded on January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and no set-aside designation was used for this award. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract, valued at up to $3,213.78, is for the delivery of 4564788163 - TELMISARTAN-AMLODIPINE 80-5 MG 30S, a pharmaceutical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type. It has an Ultimate Completion Date of June 4, 2024. This contract is...
- This federal contract award, with the ID SPE2DB22D1202|SPE2DB25FUMS5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,874.32 firm fixed-price delivery order is for the supply of Telmisartan-Amlodipine 80-10 medication, with a completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.25 firm fixed-price delivery order covers the supply of Telmisartan-Amlodipine 40-10 30S, a cardiovascular medication, with a period of performance through November 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,004.26 firm-fixed-price delivery order is for the supply of 4563134465 TELMISARTAN 80 MG TABLET 30S, a cardiovascular medication, with a completion date of December 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,059.82, is for the delivery of TELMISARTAN 40 MG TABLET 30S, a cardiovascular medication. It is a firm fixed-price delivery order contract with a completion date of November 13, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999...
- This contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,998.58 firm fixed price delivery order is for the pharmaceutical product Telmisartan-Amlodipine 40-5 mg, with a completion date of June 29, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,127.09, is for the delivery of TELMISARTAN-AMLODIPINE 40-5 MG 30S, a cardiovascular medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. The award is not designated with a set-aside...
- This federal contract award, SPE2DB20D3103|SPE2DB24FP0C5, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,230.28 firm fixed-price delivery order is for the supply of Telmisartan-Amlodipine 80-5 mg tablets. The contract has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQXP2Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $4,285.23 firm-fixed-price delivery order contract SPE2DB20D3101|SPE2DB24FQXP2 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4563172782 TELMISARTAN-AMLODIPINE 80-10 30S medical products. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to military healthcare programs. The contract has an ultimate completion date of December 26, 2023 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen's extensive capabilities in distributing essential medical commodities, including specialty medications, generic drugs, and medical devices, make the company a key vendor supporting federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 12/22/23 |